Understand the source comparison
Selectivity Trade-offs vs Ipamorelin
The comparison between Hexarelin and Ipamorelin is one of the most practically important distinctions in GHRP research. Both are GHSR agonists. Both stimulate GH release. The critical difference is selectivity. Ipamorelin was specifically developed to be selec
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The comparison between Hexarelin and Ipamorelin is one of the most practically important distinctions in GHRP research. Both are GHSR agonists. Both stimulate GH release. The critical difference is selectivity.
- Ipamorelin was specifically developed to be selective: it activates the GHSR with high efficacy while producing minimal stimulation of ACTH/cortisol or prolactin secretion. This selectivity is what makes Ipamorelin the workhorse GHRP for most research applications — experiments can attribute observed effects to GH without needing to account for concurrent cortisol or prolactin elevation.
- Hexarelin is less selective. At higher concentrations, it stimulates cortisol (via ACTH) and prolactin alongside GH. In body composition research, this matters because cortisol is catabolic — it promotes protein breakdown and fat accumulation. If a Hexarelin study produces changes in muscle or fat endpoints, the researcher must consider whether GH or cortisol (or both) contributed to those outcomes.
- The research design implication: use Ipamorelin when clean GH-specific results are the priority; use Hexarelin when maximum GH amplitude is the priority and you can control for or account for the cortisol/prolactin elevation in your analysis. For studies that include both compounds, the comparison itself becomes data — the differential effects between Hexarelin and Ipamorelin can reveal what the cortisol/prolactin contribution to an observed outcome actually is.